IL18 and neoplasm: More advanced fourth-generation CARs, known as T cell Redirected for Universal Cytokine Killing, are engineered to secrete immunostimulatory cytokines like IL-12, IL-15, or IL-18, thereby enhancing anti-tumor efficacy and modulating the tumor microenvironment (90).